{"transactions":[{"id":3169320,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":149660,"kind":"person","name":"Gupta Ajay","position":1,"cik":"0001466676","reported_name":"Gupta Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Scientific Off."}}],"security":"Common Stock","published_at":"2020-04-27T18:37:36.000Z","date":"2020-04-26","kind":"tax_withholding","acquired":false,"shares":1758,"price":2.27,"value":3990.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares surrendered to the Issuer in satisfaction of the payment of required withholding taxes in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 11,334 shares of common stock underlying unvested restricted stock unit awards that vest based on the achievement of time-based milestones."}],"balance_after":574700,"source":{"system":"sec-edgar","filing":"0001628280-20-005497","document":"wf-form4_158801263545010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828020005497/wf-form4_158801263545010.xml","form_type":"4"}},{"id":3393817,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":149660,"kind":"person","name":"Gupta Ajay","position":1,"cik":"0001466676","reported_name":"Gupta Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Scientific Off."}}],"security":"Common Stock","published_at":"2019-10-15T21:00:52.000Z","date":"2019-10-07","kind":"tax_withholding","acquired":false,"shares":31491,"price":2.53,"value":79672.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares surrendered to the Issuer in satisfaction of the payment of required withholding taxes in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 17,000 shares of common stock underlying unvested restricted stock unit awards."}],"balance_after":576458,"source":{"system":"sec-edgar","filing":"0001104659-19-054199","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465919054199/a4.xml","form_type":"4"}},{"id":3545703,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":149660,"kind":"person","name":"Gupta Ajay","position":1,"cik":"0001466676","reported_name":"Gupta Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Scientific Off."}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-30T20:31:04.000Z","date":"2019-04-25","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest in three equal installments on the first, second and third anniversaries of April 25, 2019, subject to the Reporting Person's continued employment with the Issuer."}],"balance_after":28000,"derivative":{"exercise_price":4.81,"expiration_date":"2029-04-25","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001104659-19-025343","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465919025343/a4.xml","form_type":"4"}},{"id":3545702,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":149660,"kind":"person","name":"Gupta Ajay","position":1,"cik":"0001466676","reported_name":"Gupta Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Scientific Off."}}],"security":"Common Stock","published_at":"2019-04-30T20:31:04.000Z","date":"2019-04-25","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest in three equal installments on the first, second and third anniversaries of April 25, 2019, subject to the Reporting Person's continued employment with the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units vest in three equal installments on the first, second and third anniversaries of April 25, 2019, subject to the Reporting Person's continued employment with the Issuer."}],"balance_after":607949,"source":{"system":"sec-edgar","filing":"0001104659-19-025343","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465919025343/a4.xml","form_type":"4"}},{"id":3792039,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":149660,"kind":"person","name":"Gupta Ajay","position":1,"cik":"0001466676","reported_name":"Gupta Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Scientific Off."}}],"security":"Common Stock","published_at":"2018-10-12T20:54:47.000Z","date":"2018-10-07","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock grant. Restrictions lapse as to all of the shares on October 7, 2019, subject to the Reporting Person's continued employment with the Issuer."}],"balance_after":590949,"source":{"system":"sec-edgar","filing":"0001104659-18-061831","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465918061831/a4.xml","form_type":"4"}},{"id":4273693,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":149660,"kind":"person","name":"Gupta Ajay","position":1,"cik":"0001466676","reported_name":"Gupta Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-06-23T20:56:30.000Z","date":"2017-06-21","kind":"tax_withholding","acquired":false,"shares":69218,"price":7.2,"value":498369.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares surrendered to Company in order to satisfy withholding tax obligations."}],"balance_after":490949,"source":{"system":"sec-edgar","filing":"0001209191-17-041695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000120919117041695/doc4.xml","form_type":"4"}},{"id":4373788,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":149660,"kind":"person","name":"Gupta Ajay","position":1,"cik":"0001466676","reported_name":"Gupta Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-03-23T22:40:56.000Z","date":"2017-03-21","kind":"grant","acquired":true,"shares":68500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Performance-based stock grant. This grant vests upon the earliest to occur of any of the following (a) reported net sales of the company in any four consecutive calendar quarters equals or exceeds $100,000,000, (b) the market capitalization of the company is greater than $600,000,000 for ten consecutive trading days, or (c) one year following the date the Centers for Medicare & Medicaid Services assign the company transitional add on reimbursement payment status for the drug product, Triferic."}],"balance_after":560167,"source":{"system":"sec-edgar","filing":"0001209191-17-022662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000120919117022662/doc4.xml","form_type":"4"}}]}